Table 1.

Adhesion molecule expression on lymphocytes treated with fucoidan and SDF-1




Control

Fucoidan

SDF-1

Fucoidan + SDF-1
β2 integrin   42.5 ± 3.48   42.9 ± 3.43   46.4 ± 3.27   50.2 ± 1.15  
Active β2 integrin   7.2 ± 0.69   8.5 ± 0.96   14.9 ± 2.67*  18.5 ± 4.18 
β1 integrin   28.9 ± 2.22   28.5 ± 2.80   29.3 ± 4.07   30.1 ± 4.62  
Active β1 integrin   4.5 ± 0.76   4.6 ± 0.69   6.3 ± 1.26   5.5 ± 0.68  
L-selectin
 
108.4 ± 7.14
 
94.1 ± 12.12
 
98.7 ± 7.42
 
71.1 ± 8.20*
 



Control

Fucoidan

SDF-1

Fucoidan + SDF-1
β2 integrin   42.5 ± 3.48   42.9 ± 3.43   46.4 ± 3.27   50.2 ± 1.15  
Active β2 integrin   7.2 ± 0.69   8.5 ± 0.96   14.9 ± 2.67*  18.5 ± 4.18 
β1 integrin   28.9 ± 2.22   28.5 ± 2.80   29.3 ± 4.07   30.1 ± 4.62  
Active β1 integrin   4.5 ± 0.76   4.6 ± 0.69   6.3 ± 1.26   5.5 ± 0.68  
L-selectin
 
108.4 ± 7.14
 
94.1 ± 12.12
 
98.7 ± 7.42
 
71.1 ± 8.20*
 

Results (MFI) are given as mean ± SEM. Human T lymphocytes were stimulated with fucoidan, SDF-1, or both. Cell surface β2 integrin and activation-associated epitope were detected by antibodies 60.3 and mAb24, respectively, using flow cytometry. Surface β1 integrin and activation-associated epitope were detected by antibodies HP2/1 and HUTS-21, respectively. L-selectin was detected by LAM1-116.

*

P < .05 compared with control.

P < .01 compared with control.

Close Modal

or Create an Account

Close Modal
Close Modal